Great Valley Advisor Group’s GSK GSK Stock Holding History

Great Valley Advisor Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$326K	Sell	6,223 -58	-0.9%	-$3.07K	0.01%	830
2026 Q1	$347K	Buy	6,281 +1,893	+43%	+$103K	0.01%	780
2025 Q4	$216K	Buy	+4,388	New	+$205K	﹤0.01%	879
2022 Q1	–	Sell	-10,890	Closed	-$600K	–	606
2021 Q4	$600K	Sell	10,890 -1,900	-15%	-$98.8K	0.04%	351
2021 Q3	$611K	Buy	12,790 +947	+8%	+$47.6K	0.04%	319
2021 Q2	$589K	Buy	11,843 +1,099	+10%	+$52.8K	0.04%	312
2021 Q1	$479K	Buy	10,744 +2,928	+37%	+$133K	0.05%	311
2020 Q4	$360K	Buy	+7,816	New	+$359K	0.04%	340

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Great Valley Advisor Group's GSK Position: Q2 2026 in Review

Great Valley Advisor Group reduced its GSK (GSK) stake by 0.92% in Q2 2026, selling an estimated $3.07K and leaving 6,223 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #830.

Great Valley Advisor Group first reported a position in GSK in Q4 2020 and has held it in 8 quarters since. The position peaked at $611K in Q3 2021. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Great Valley Advisor Group held 6,223 shares of GSK worth $326K as of Q2 2026.
Great Valley Advisor Group sold 58 GSK shares in Q2 2026, an estimated $3.07K.
GSK made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #830 holding.
Great Valley Advisor Group first reported a position in GSK in Q4 2020 and has held it in 8 quarters since.
Great Valley Advisor Group's GSK position peaked at $611K in Q3 2021.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.